| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.23▼ | 4.23▼ | 4.36▼ | 3.94▲ | 4.49▼ |
| MA10 | 4.61▼ | 4.49▼ | 4.21▼ | 4.21▲ | 4.67▼ |
| MA20 | 4.48▼ | 4.45▼ | 4.46▼ | 4.46▼ | 3.88▲ |
| MA50 | 4.59▼ | 4.26▼ | 4.02▼ | 4.61▼ | 4.61▼ |
| MA100 | 3.93▲ | 3.74▲ | 3.69▲ | 3.81▲ | 5.60▼ |
| MA200 | 3.75▲ | 4.38▼ | 4.73▼ | 4.24▲ | 5.29▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.085▼ | -0.079▼ | -0.084▼ | -0.044▼ | 0.110▲ |
| RSI | 43.518▼ | 45.100▼ | 44.285▼ | 50.178▲ | 51.877▲ |
| STOCH | 20.323 | 28.889 | 38.028 | 17.182▼ | 48.178 |
| WILL %R | -76.839▼ | -76.839▼ | -76.839▼ | -62.890 | -56.203 |
| CCI | -51.317 | -42.171 | -63.838 | -19.475 | 48.251 |
|
Sunday, September 14, 2025 06:39 PM
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the successful commercial launch of Ryoncil® (remestemcel-L-rknd), ...
|
|
Friday, September 12, 2025 11:15 AM
As the U.S. stock market navigates a mixed landscape with the Dow slipping and the Nasdaq reaching new highs, investors are keeping a close eye on potential interest rate cuts by the Federal Reserve.
|
|
Thursday, September 11, 2025 07:07 AM
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/09/25 | 4.21 | 4.50 | 3.89 | 4.41 | 39,700 |
| 11/09/25 | 3.37 | 6.63 | 3.10 | 4.74 | 766,000 |
| 10/09/25 | 3.72 | 3.72 | 3.38 | 3.45 | 5,200 |
| 09/09/25 | 3.442 | 3.58 | 3.37 | 3.58 | 26,896 |
| 08/09/25 | 3.85 | 3.86 | 3.53 | 3.53 | 13,845 |
| 05/09/25 | 4.13 | 4.13 | 3.83 | 3.85 | 2,356 |
| 04/09/25 | 4.53 | 4.53 | 3.958 | 4.13 | 8,518 |
| 03/09/25 | 4.93 | 4.9459 | 4.66 | 4.66 | 13,127 |
| 02/09/25 | 4.84 | 4.9984 | 4.84 | 4.92 | 10,777 |
| 29/08/25 | 4.82 | 4.82 | 4.82 | 4.82 | 1,257 |
|
|
||||
|
|
||||
|
|